Abstract:Epithelial-to-mesenchymal transitions (EMTs) are phenotypic plasticity processes that confer migratory and invasive properties to epithelial cells during development, wound-healing, fibrosis and cancer<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>. EMTs are driven by SNAIL, ZEB and TWIST transcription factors<a href="/articles/s41586-019-1897-5#ref-CR5">5</a>,<a href="/articles/s41586-019-1897-5#ref-CR6">6</a> together with microRNAs that balance this regulatory network<a href="/articles/s41586-019-1897-5#ref-CR7">7</a>,<a href="/articles/s41586-019-1897-5#ref-CR8">8</a>. Transforming growth factor β (TGF-β) is a potent inducer of developmental and fibrogenic EMTs<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR9">9</a>,<a href="/articles/s41586-019-1897-5#ref-CR10">10</a>. Aberrant TGF-β signalling and EMT are implicated in the pathogenesis of renal fibrosis, alcoholic liver disease, non-alcoholic steatohepatitis, pulmonary fibrosis and cancer<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR11">11</a>. TGF-β depends on RAS and mitogen-activated protein kinase (MAPK) pathway inputs for the induction of EMTs<a href="#ref-CR12">12</a>,<a href="#ref-CR13">13</a>,<a href="#ref-CR14">14</a>,<a href="#ref-CR15">15</a>,<a href="#ref-CR16">16</a>,<a href="#ref-CR17">17</a>,<a href="#ref-CR18">18</a>,<a href="/articles/s41586-019-1897-5#ref-CR19">19</a>. Here we show how these signals coordinately trigger EMTs and integrate them with broader pathophysiological processes. We identify RAS-responsive element binding protein 1 (RREB1), a RAS transcriptional effector<a href="/articles/s41586-019-1897-5#ref-CR20">20</a>,<a href="/articles/s41586-019-1897-5#ref-CR21">21</a>, as a key partner of TGF-β-activated SMAD transcription factors in EMT. MAPK-activated RREB1 recruits TGF-β-activated SMAD factors to SNAIL. Context-dependent chromatin accessibility dictates the ability of RREB1 and SMAD to activate additional genes that determine the nature of the resulting EMT. In carcinoma cells, TGF-β–SMAD and RREB1 directly drive expression of SNAIL and fibrogenic factors stimulating myofibroblasts, promoting intratumoral fibrosis and supporting tumour growth. In mouse epiblast progenitors, Nodal–SMAD and RREB1 combine to induce expression of SNAIL and mesendoderm-differentiation genes that drive gastrulation. Thus, RREB1 provides a molecular link between RAS and TGF-β pathways for coordinated induction of developmental and fibrogenic EMTs. These insights increase our understanding of the regulation of epithelial plasticity and its pathophysiological consequences in development, fibrosis and cancer.

Transcription Factor RREB1: from Target Genes towards Biological Functions

Identification of cis-regulatory elements and trans-acting proteins of the rat carbohydrate response element binding protein gene.

RREB1 could act as an immunological and prognostic biomarker: From comprehensive analysis to osteosarcoma validation

Loss of RREB1 reduces adipogenesis and improves insulin sensitivity in mouse and human adipocytes

The Pathophysiological Roles and Regulatory Mechanism of Retinoic Acid Receptor-related Orphan Receptors

RREB1 regulates neuronal proteostasis and the microtubule network

Rreb1 is a key transcription factor in Sertoli cell maturation and function and spermatogenesis in mouse

Identification and Characterization of RHEBL1 , a Novel Member of Ras Family, which Activates Transcriptional Activities of NF-Kappa B

REV1: A Novel Biomarker and Potential Therapeutic Target for Various Cancers.

Systematical analysis reveals a strong cancer relevance of CREB1-regulated genes

Rbb, A Novel Transcription Repressor, Represses the Transcription of Hdm2 Oncogene

A novel interaction between RNA m6A methyltransferase METTL3 and RREB1

Activation of transcriptional activities of AP1 and SRE by a novel zinc finger protein ZNF445.

The Regulatory Network of CREB3L1 and Its Roles in Physiological and Pathological Conditions

RREB1 Promotes the Development of Parafollicular Carcinogenesis Through the Ras-Raf-1-ELK3 Signaling Pathway

Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives

The HBP1 transcriptional repressor participates in RAS-induced premature senescence.

Crucial Amino Acids in Transcription Regulatory Domain for DREB1A-like Transcription Activation

Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling

REST In Good Times and Bad: Roles In Tumor Suppressor and Oncogenic Activities

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1